The mRNA level of Farnesoid X Receptor (FXR) is suppressed in the liver and terminal ileum of hens with fatty liver, suggesting that FXR suppression disrupts lipid homeostasis, contributing to lipid accumulation and heightened NAFLD risk [74]. Here, NR1H4 is linked to metabolic dysfunction-associated steatotic liver disease.